Media Center
News
February 12th, 2013 - EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
January 9th, 2013 - Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum
November 14th, 2012 - EpiCept Reports Third Quarter 2012 Operating and Financial Results
November 12th, 2012 - EpiCept to Report Third Quarter 2012 Operating and Financial Results on November 14, 2012
November 8th, 2012 - Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
Publications
Oncology
Hellstrand K, Hermodsson S.
Histamine H2-receptor-mediated regulation of human natural killer cell activity.
>> More
Pain Management
Sawynok J, Esser MJ, Reid AR
Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 82 (1999) 149-158.
>> More
Events
November 14th, 2012 - EpiCept Corporation Third Quarter-2012 Earnings Call
August 8th, 2012 - EpiCept Corporation Second Quarter-2012 Earnings Call
February 29th, 2012 - EpiCept Corporation Fourth Quarter-Year End 2011 Earnings Call
February 13th, 2012 - BIO CEO & Investor Conference
January 10th, 2012 - 2012 OneMedForum